Get ready for a new paradigm in home care accreditation

Episode 8: Stay in Sync with Innovations in Medication Decision Support

FDA approves Biktarvy for HIV treatment in patients not virologically suppressed, enhancing options for those restarting antiretroviral therapy.

Drug Topics staff

FDA Approves Finerenone for Heart Failure With Left Ventricular Ejection Fraction

Podcast

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

The approval is based on the FINEARTS-HF (NCT04435626), showing that the drug achieved a 16% relative risk reduction of cardiovascular death and total heart failure events.

FDA Approves Sebetralstat for Hereditary Angioedema

The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026.

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

The therapy is now the first and only oral on-demand treatment option for the condition.

FDA Approves Biktarvy for Patients With HIV Previously Treated With Antiretroviral Therapy

This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.

Related Content

Episode 8: Stay in Sync with Innovations in Medication Decision Support

FDA approves Biktarvy for HIV treatment in patients not virologically suppressed, enhancing options for those restarting antiretroviral therapy.

Drug Topics staff

FDA Approves Finerenone for Heart Failure With Left Ventricular Ejection Fraction

Podcast

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

The approval is based on the FINEARTS-HF (NCT04435626), showing that the drug achieved a 16% relative risk reduction of cardiovascular death and total heart failure events.

FDA Approves Sebetralstat for Hereditary Angioedema

The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026.

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

The therapy is now the first and only oral on-demand treatment option for the condition.